Fabio Eisfeld: Plasma-derived Drugs Cannot Be Produced Synthetically, They Depend Entirely On The Generosity of Healthy Donors
Fabio Eisfeld, HR Manager Latam at Grifols, shared on LinkedIn:
”Last week, we celebrated International Plasma Awareness Week (IPAW2025 ), and Grifols employees in Latin America actively participated!
Here are photos of colleagues dressed in yellow to contribute to this important moment.
Created by the Plasma Protein Therapeutics Association (PPTA), IPAW is dedicated to highlighting the value of human plasma, recognizing the generosity of donors, and promoting understanding of plasma-derived therapies.
Plasma-derived drugs cannot be produced synthetically; they depend entirely on the generosity of healthy donors.
These donations provide essential proteins, which often represent the only therapy available to patients.
Millions of people around the world, both those suffering from rare and chronic diseases and those facing trauma or medical emergencies, rely on plasma-derived therapies.
We remain firm in our goal: to produce and deliver medicines that provide quality of life to our patients!”
-
Oct 13, 2025, 03:53Ganesh Mohan is Organising a Webinar to Improve Awareness About Thrombophilia on World Thrombosis Day
-
Oct 13, 2025, 02:47Thomas Reiser: Don't Miss This ISTH Research Recap with Robert Sidonio, Cedric Hermans and Michael Makris
-
Oct 12, 2025, 01:30Elvira Grandone: Pregnancy and VTE - Still A Relevant Cause of Maternal Mortality
-
Oct 12, 2025, 01:29Emilia Arturo: Consider Submitting the Paper and Its Reviews for a Second Look Rapid Response From One of These Blood Journals
-
Oct 12, 2025, 01:22Christina (Tina) P.: APS is Responsible for 1 in 3 Strokes in People Under 50 and The N1 Cause of Stroke in Young People
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 01:32Camila V. Blair and Colleagues on The Association of CAD by Coronary CT Angiography and Cardiovascular Outcomes in Psoriatic Disease
-
Oct 12, 2025, 01:26Caroline Dixon and Colleagues on LMWH Dosing to Reduce The Risk of VTE in Pregnant Women With Inherited ATD
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 13, 2025, 03:44Jorge Monge: It Was An Honor to Take Part in the 3rd EBA Workshop on Rare Blood Provision
-
Oct 13, 2025, 03:15Arun V. J: They Chose Death Over A Blood Transfusion — And Here’s Why I Stopped Judging Them
-
Oct 13, 2025, 03:13Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes - A Call for Greater Inclusion
-
Oct 13, 2025, 02:50Emmanuel J Favaloro: Again Promoting World Thrombosis Day - October 13
-
Oct 12, 2025, 01:33Stefan Galisch: This Week We Celebrate IPAW– A Global Initiative That Raises Awareness of The Life-saving Importance of Plasma Donation